1

Biotech Investor Relations Jobs (NOW HIRING)

Manager, Investor Relations

Manhattan, NY · On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

Manager, Investor Relations

Manhattan, NY · On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

Department: 101200 Investor Relations Location: San Diego Be a part of a global team that is ... Strong interest in capital markets, investing, biotechnology, healthcare, and current events ...

Director, Investor Relations

Waltham, MA · Hybrid

$188K - $235K/yr

Zenas BioPharma is seeking an accomplished Director of Investor Relations to lead the development ... biotechnology or the life sciences; experience in a publicly traded biotech company strongly ...

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

Job Title Head of Investor Relations Requisition JR000015345 Head of Investor Relations (Open ... Prior pharmaceutical/biotech experience is required. * Strong understanding of financial statements ...

Job Title Head of Investor Relations Requisition JR000015345 Head of Investor Relations (Open ... Prior pharmaceutical/biotech experience is required. * Strong understanding of financial statements ...

next page

Showing results 1-20

Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do biotech investor relations jobs pay per year?

As of Jul 28, 2026, the average yearly pay for biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What types of teams or departments does a Biotech Investor Relations professional typically interact with?

Biotech Investor Relations professionals regularly collaborate with executive leadership, finance, research and development, legal, and marketing teams. Their role requires gathering up-to-date information on scientific progress, financial results, and strategic initiatives to share with current and potential investors. They often coordinate meetings or events where senior scientists and executives meet with stakeholders, ensuring consistency and accuracy of messaging. This collaborative environment helps ensure that all communications with the investment community reflect the company's achievements, pipeline developments, and business objectives effectively.

What is a Biotech Investor Relations job?

A Biotech Investor Relations (IR) professional manages communication between a biotechnology company and its investors, analysts, and stakeholders. Their role includes crafting financial reports, preparing earnings calls, and ensuring transparency about the company's performance, pipeline progress, and strategic direction. They also help maintain investor confidence by addressing concerns, organizing meetings, and staying compliant with financial regulations. Effective IR professionals bridge the gap between the company's scientific advancements and the financial community, translating complex biotech developments into clear, investor-friendly messaging.

What are the key skills and qualifications needed to thrive in the Biotech Investor Relations position, and why are they important?

Excelling in Biotech Investor Relations requires a strong background in finance, biotechnology, and communications, often supported by a relevant degree such as finance, biology, business, or communications. Familiarity with investor relations software (like Q4 or IR Insight), financial modeling tools, and, in some cases, certifications such as the Investor Relations Charter (IRC) is advantageous. Outstanding interpersonal, presentation, and strategic thinking skills set top candidates apart, as they frequently liaise between executives, investors, and scientists. These competencies are vital to effectively communicate complex scientific information to investors, maintain regulatory compliance, and build trust in a highly regulated and innovation-driven industry.

What cities are hiring for Biotech Investor Relations jobs? Cities with the most Biotech Investor Relations job openings:
What are the most commonly searched types of Biotech Investor Relations jobs? The most popular types of Biotech Investor Relations jobs are:
What states have the most Biotech Investor Relations jobs? States with the most job openings for Biotech Investor Relations jobs include:
Infographic showing various Biotech Investor Relations job openings in the United States as of July 2026, with employment types broken down into 2% As Needed, 90% Full Time, 1% Part Time, 1% Temporary, and 6% Contract. Highlights an 82% Physical, 3% Hybrid, and 15% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.
Associate Director, Investor Relations

Associate Director, Investor Relations

Beam Therapeutics

Cambridge, MA

Other

Posted 10 days ago


Job description

Position Overview:

Beam is seeking a highly motivated and strategic Associate Director, Investor Relations to join our growing Investor Relations and External Communications team at a pivotal moment in the company's evolution. In this role, you will support the execution of Beam's investor relations strategy and play a central part in shaping how Beam's science, pipeline, and corporate narrative are communicated to the investment community. You will partner closely with senior leadership, finance, legal, corporate communications, and program teams to translate complex clinical and scientific milestones into clear, compelling, investor-ready messaging across earnings cycles, conferences, and one-on-one engagements. This position is critical to building a best-in-class IR function as Beam transitions from a clinical-stage to commercial-stage biotechnology company delivering on the promise of base editing for patients with serious diseases.

Key Responsibilities:

  • Support execution of Beam's investor relations strategy, including proactive engagement with buy-side and sell-side investors.
  • Help manage investor targeting, outreach, and meeting coordination for one-on-ones, conferences, and non-deal roadshows.
  • Track investor sentiment, ownership trends, and peer activity to inform outreach strategy and positioning.
  • Serve as a secondary point of contact for inbound investor and analyst inquiries.
  • Support continuous improvement of IR best practices and infrastructure.
  • Support preparation of key disclosures and quarterly earnings materials, including scripts, slide decks, Q&A documents, and press releases.
  • Help ensure accuracy, consistency, and compliance across external disclosures in coordination with legal and finance.
  • Manage internal consensus models.
  • Work cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones; translate technical data into clear, investor-relevant narratives; and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution.
  • Help refine and maintain Beam's corporate narrative as the company evolves from a clinical-stage to commercial-stage biotech.
  • Assist in message testing and preparation of executive spokespeople.
  • Manage updates to Beam's investor website and coordinate with Corporate Communications on broader digital and website strategy and content.

Required Qualifications:

  • 5-8 years of experience in investor relations, equity research, investment banking, corporate finance, or strategic communications, with meaningful exposure to public biotechnology or life sciences companies.
  • Strong understanding of capital markets, public company disclosure requirements, and investor expectations.
  • Ability to synthesize complex scientific, clinical, and financial information into clear, concise messaging.
  • Proven written and verbal communication skills.
  • High attention to detail and strong project management capabilities.
  • Comfortable operating in a fast-paced, highly cross-functional environment.

Preferred Qualifications:

  • Prior experience supporting a pipeline-driven biotech company with multiple clinical programs.
  • Exposure to companies approaching or undergoing a transition to commercial stage.
  • Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities.
  • Experience interacting directly with investors or analysts.